JPS6041077B2
(ja)
|
1976-09-06 |
1985-09-13 |
喜徳 喜谷 |
1,2‐ジアミノシクロヘキサン異性体のシス白金(2)錯体
|
US4261989A
(en)
|
1979-02-19 |
1981-04-14 |
Kaken Chemical Co. Ltd. |
Geldanamycin derivatives and antitumor drug
|
JPS62135832A
(ja)
|
1985-12-09 |
1987-06-18 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラ−写真感光材料の処理方法
|
JPS62135834A
(ja)
|
1985-12-09 |
1987-06-18 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラ−写真感光材料の処理方法
|
JPS62135830A
(ja)
|
1985-12-09 |
1987-06-18 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラ−写真感光材料及びその処理方法
|
JPS62135835A
(ja)
|
1985-12-09 |
1987-06-18 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラ−写真感光材料の処理方法
|
JPS62136651A
(ja)
|
1985-12-10 |
1987-06-19 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラー写真感光材料の処理方法
|
JPS62136654A
(ja)
|
1985-12-10 |
1987-06-19 |
Fuji Photo Film Co Ltd |
ハロゲン化銀写真感光材料の処理方法
|
JPS62136650A
(ja)
|
1985-12-11 |
1987-06-19 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラ−写真感光材料及びその処理方法
|
JPS62206545A
(ja)
|
1986-03-07 |
1987-09-11 |
Fuji Photo Film Co Ltd |
ハロゲン化銀写真感光材料
|
GB8729614D0
(en)
|
1987-12-18 |
1988-02-03 |
Beecham Group Plc |
Novel compounds
|
US5266573A
(en)
|
1989-08-07 |
1993-11-30 |
Elf Sanofi |
Trifluoromethylphenyltetrahydropyridines for the treatment and/or prophylaxis of intestinal motility disorders
|
US5360459A
(en)
|
1991-05-13 |
1994-11-01 |
The Lubrizol Corporation |
Copper-containing organometallic complexes and concentrates and diesel fuels containing same
|
JPH05196976A
(ja)
|
1991-11-18 |
1993-08-06 |
Toshiba Corp |
有機非線形光学材料
|
JPH05181221A
(ja)
|
1991-12-27 |
1993-07-23 |
Konica Corp |
ハロゲン化銀写真感光材料
|
GB9201755D0
(en)
|
1992-01-28 |
1992-03-11 |
British Bio Technology |
Compounds
|
FR2687932A1
(fr)
|
1992-02-27 |
1993-09-03 |
Oreal |
Dispersion huile-dans-l'eau susceptible de former des films composites.
|
EP0647450A1
(en)
|
1993-09-09 |
1995-04-12 |
BEHRINGWERKE Aktiengesellschaft |
Improved prodrugs for enzyme mediated activation
|
HRP970371A2
(en)
|
1996-07-13 |
1998-08-31 |
Kathryn Jane Smith |
Heterocyclic compounds
|
AU3785597A
(en)
|
1996-08-14 |
1998-03-06 |
Takeda Chemical Industries Ltd. |
Cyclic urea compounds, their production and use as herbicides
|
US5977134A
(en)
|
1996-12-05 |
1999-11-02 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
US6117973A
(en)
|
1997-02-24 |
2000-09-12 |
Georgia Tech Research Corp. |
PNA monomers with electron donor or acceptor
|
FR2761687B1
(fr)
|
1997-04-08 |
2000-09-15 |
Centre Nat Rech Scient |
Derives de quinoleines, possedant notamment des proprietes antivirales, leurs preparations et leurs applications biologiques
|
JP2000072695A
(ja)
|
1998-08-24 |
2000-03-07 |
Sumitomo Pharmaceut Co Ltd |
環状化合物
|
ATE313535T1
(de)
|
1999-05-21 |
2006-01-15 |
|
Pyrazinyl-piperazin-verbindungen, ihre anwendung und herstellung
|
US6465467B1
(en)
|
1999-05-21 |
2002-10-15 |
Biovitrum Ab |
Certain aryl-aliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases
|
PE20010306A1
(es)
|
1999-07-02 |
2001-03-29 |
Agouron Pharma |
Compuestos de indazol y composiciones farmaceuticas que los contienen utiles para la inhibicion de proteina kinasa
|
EP1204645A2
(en)
|
1999-08-04 |
2002-05-15 |
Millennium Pharmaceuticals, Inc. |
Melanocortin-4 receptor binding compounds and methods of use thereof
|
US6699873B1
(en)
|
1999-08-04 |
2004-03-02 |
Millennium Pharmaceuticals, Inc. |
Melanocortin-4 receptor binding compounds and methods of use thereof
|
US6514964B1
(en)
|
1999-09-27 |
2003-02-04 |
Amgen Inc. |
Fused cycloheptane and fused azacycloheptane compounds and their methods of use
|
DE60024651T2
(de)
|
1999-09-28 |
2006-09-28 |
Eisai Co., Ltd. |
Chinuclidin-verbindungen und medikamente die diese als aktive wirkstoffe enthalten
|
GB0018891D0
(en)
|
2000-08-01 |
2000-09-20 |
Novartis Ag |
Organic compounds
|
JP4548761B2
(ja)
|
2000-06-15 |
2010-09-22 |
富士フイルムホールディングス株式会社 |
潤滑剤組成物
|
WO2002000651A2
(en)
|
2000-06-27 |
2002-01-03 |
Bristol-Myers Squibb Pharma Company |
Factor xa inhibitors
|
DE10032633A1
(de)
|
2000-07-05 |
2002-01-17 |
Bayer Ag |
Verfahren zum Auffinden von Hemmstoffen der Protoporphyrinogen-Oxidase
|
JP2002122954A
(ja)
|
2000-08-08 |
2002-04-26 |
Fuji Photo Film Co Ltd |
感光性ハロゲン化銀写真乳剤、これを含有するハロゲン化銀写真感光材料および感光性ハロゲン化銀写真乳剤の感度向上方法
|
AU2001279955A1
(en)
|
2000-08-18 |
2002-03-04 |
Sterix Limited |
2-substituted estradiol derivative for inhibiting superoxid dismutase
|
US6963001B2
(en)
|
2000-09-30 |
2005-11-08 |
Henkel Corporation |
Low shrinkage thermosetting resin compositions and methods of use therefor
|
WO2002028813A1
(en)
|
2000-09-30 |
2002-04-11 |
Loctite |
Low shrinkage thermosetting resin compositions and methods of use therefor
|
AU2002213467A1
(en)
|
2000-10-11 |
2002-04-22 |
Chemocentryx, Inc. |
Modulation of ccr4 function
|
EP1217000A1
(en)
|
2000-12-23 |
2002-06-26 |
Aventis Pharma Deutschland GmbH |
Inhibitors of factor Xa and factor VIIa
|
US6995162B2
(en)
|
2001-01-12 |
2006-02-07 |
Amgen Inc. |
Substituted alkylamine derivatives and methods of use
|
SE0103646D0
(sv)
|
2001-11-01 |
2001-11-01 |
Astrazeneca Ab |
Therapeutic chroman compounds
|
MXPA03006268A
(es)
|
2001-01-16 |
2003-09-22 |
Astrazeneca Ab |
Compuestos terapeuticos de cromano.
|
AU2002217742B2
(en)
|
2001-01-16 |
2008-02-21 |
Astrazeneca Ab |
Therapeutic heterocyclic compounds
|
KR20030078958A
(ko)
|
2001-03-01 |
2003-10-08 |
시오노기세이야쿠가부시키가이샤 |
Hiv 인테그라제 저해 활성을 갖는 질소 함유의헤테로아릴 화합물
|
PT1383731E
(pt)
|
2001-04-06 |
2009-11-03 |
Biocryst Pharm Inc |
Compostos de biarilo como inibidores de serina-protease
|
WO2003003009A1
(en)
|
2001-06-29 |
2003-01-09 |
7Tm Pharma A/S |
Use of metal-ion chelates in validating biological molecules as drug targets in test animal models
|
WO2003003008A1
(en)
|
2001-06-29 |
2003-01-09 |
7Tm Pharma A/S |
Chemical libraries useful for drug discovery processes
|
JO3429B1
(ar)
|
2001-08-13 |
2019-10-20 |
Janssen Pharmaceutica Nv |
مشتقات برميدينات مثبطة فيروس الايدز
|
FR2831536A1
(fr)
|
2001-10-26 |
2003-05-02 |
Aventis Pharma Sa |
Nouveaux derives de benzimidazoles, leur procede de preparation, leur application a titre de medicament, compositions pharmaceutiques et nouvelle utilisation notamment comme inhibiteurs de kdr
|
US6897208B2
(en)
|
2001-10-26 |
2005-05-24 |
Aventis Pharmaceuticals Inc. |
Benzimidazoles
|
US20030187026A1
(en)
|
2001-12-13 |
2003-10-02 |
Qun Li |
Kinase inhibitors
|
IL162734A0
(en)
|
2002-02-01 |
2005-11-20 |
Ariad Gene Therapeutics Inc |
Phosphorus-containing compounds & uses thereof
|
KR100975784B1
(ko)
|
2002-03-05 |
2010-08-17 |
머크 프로스트 캐나다 리미티드 |
카텝신 시스테인 프로테아제 억제제
|
WO2003078446A2
(en)
|
2002-03-15 |
2003-09-25 |
Nuevolution A/S |
A building block forming a c-c or a c-hetero atom bond upon reaction
|
TWI275390B
(en)
|
2002-04-30 |
2007-03-11 |
Wyeth Corp |
Process for the preparation of 7-substituted-3- quinolinecarbonitriles
|
EP1545502A4
(en)
|
2002-08-23 |
2008-12-24 |
Univ Connecticut |
KETO CANNABINOIDS WITH THERAPEUTIC INDICATIONS
|
WO2004056746A1
(en)
|
2002-12-23 |
2004-07-08 |
4Sc Ag |
Cycloalkene dicarboxylic acid compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
|
EP2385040A1
(en)
|
2003-03-14 |
2011-11-09 |
ONO Pharmaceutical Co., Ltd. |
Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient
|
GB0306430D0
(en)
|
2003-03-20 |
2003-04-23 |
Bp Chem Int Ltd |
Polymerisation and oligomerisation catalysts
|
WO2004110350A2
(en)
|
2003-05-14 |
2004-12-23 |
Torreypines Therapeutics, Inc. |
Compouds and uses thereof in modulating amyloid beta
|
JPWO2004101529A1
(ja)
|
2003-05-19 |
2006-07-13 |
小野薬品工業株式会社 |
含窒素複素環化合物およびその医薬用途
|
US7399865B2
(en)
|
2003-09-15 |
2008-07-15 |
Wyeth |
Protein tyrosine kinase enzyme inhibitors
|
JP4231379B2
(ja)
|
2003-10-15 |
2009-02-25 |
富士フイルム株式会社 |
潤滑剤組成物
|
JP2005170939A
(ja)
|
2003-11-20 |
2005-06-30 |
Takeda Chem Ind Ltd |
糖尿病の予防・治療剤
|
DE10355066A1
(de)
|
2003-11-25 |
2005-06-23 |
Basf Ag |
Verfahren zur asymmetrischen Synthese
|
US7632946B2
(en)
|
2004-02-06 |
2009-12-15 |
Abbott Laboratories |
Naphthyridine-based antibacterial compositions
|
JP4829506B2
(ja)
|
2004-02-17 |
2011-12-07 |
石原産業株式会社 |
チオアミド系化合物又はその塩、並びにそれらを含有するサイトカイン産生抑制剤
|
EP1732541A4
(en)
|
2004-04-07 |
2008-03-05 |
Takeda Pharmaceutical |
CYCLIC COMPOUNDS
|
EP1595888A1
(en)
|
2004-05-11 |
2005-11-16 |
Degussa AG |
Cycloolefin phosphine ligands and their use in catalysis
|
GB0412467D0
(en)
|
2004-06-04 |
2004-07-07 |
Astrazeneca Ab |
Chemical compounds
|
JP5315611B2
(ja)
|
2004-06-23 |
2013-10-16 |
小野薬品工業株式会社 |
S1p受容体結合能を有する化合物およびその用途
|
GB0415879D0
(en)
|
2004-07-15 |
2004-08-18 |
Bp Chem Int Ltd |
Polymerisation catalyst
|
GB0418022D0
(en)
|
2004-08-12 |
2004-09-15 |
Bp Chem Int Ltd |
Polymerisation and oligomerisation catalyst
|
CN102964294A
(zh)
|
2004-09-02 |
2013-03-13 |
遗传技术研究公司 |
Hedgehog信号转导的吡啶基抑制剂
|
GB0420396D0
(en)
|
2004-09-14 |
2004-10-13 |
Bp Chem Int Ltd |
Polyolefins
|
WO2006038594A1
(ja)
|
2004-10-04 |
2006-04-13 |
Ono Pharmaceutical Co., Ltd. |
N型カルシウムチャネル阻害薬
|
GB2436261B
(en)
|
2004-12-11 |
2010-06-09 |
Merck Patent Gmbh |
Liquid crystal compounds,liquid crystal medium and liquid crystal display
|
US20100197687A1
(en)
|
2005-01-19 |
2010-08-05 |
Benjamin Pelcman |
Indoles Useful in the Treatment of Inflammation
|
JP4749000B2
(ja)
|
2005-02-22 |
2011-08-17 |
富士フイルム株式会社 |
グリース組成物
|
US20070135437A1
(en)
|
2005-03-04 |
2007-06-14 |
Alsgen, Inc. |
Modulation of neurodegenerative diseases
|
EP1867704B1
(en)
|
2005-03-15 |
2010-09-15 |
FUJIFILM Corporation |
Surface treatment method using disc-like compound, (lubricating) composition for surface treatment, and surface-treated article
|
US20060156481A1
(en)
|
2005-03-22 |
2006-07-20 |
The Procter & Gamble Company |
Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof
|
US20070260062A1
(en)
|
2005-03-31 |
2007-11-08 |
Goetz Frederick J |
Heterocyclical Chromophore Architectures with Novel Electronic Acceptor Systems
|
ES2369714T3
(es)
|
2005-04-21 |
2011-12-05 |
Merck Serono Sa |
Pirazina sulfonamidas 2,3 sustituidas como inhibidores de crth2.
|
US8859581B2
(en)
|
2005-04-25 |
2014-10-14 |
Merck Patent Gmbh |
Azaheterocyclic compounds as kinase inhibitors
|
WO2006119800A1
(en)
|
2005-05-09 |
2006-11-16 |
Technische Universität Braunschweig |
Light emitting compound for electroluminescent applications
|
GB0510139D0
(en)
|
2005-05-18 |
2005-06-22 |
Addex Pharmaceuticals Sa |
Novel compounds B1
|
GB0510390D0
(en)
|
2005-05-20 |
2005-06-29 |
Novartis Ag |
Organic compounds
|
EP1896466B1
(en)
|
2005-06-27 |
2011-04-13 |
Bristol-Myers Squibb Company |
N-linked heterocyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
|
EP1899299B1
(en)
|
2005-06-27 |
2010-10-20 |
Bristol-Myers Squibb Company |
C-linked cyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
|
WO2007011721A1
(en)
|
2005-07-15 |
2007-01-25 |
Kalypsys, Inc. |
Inhibitors of mitotic kinesin
|
WO2007011759A2
(en)
|
2005-07-15 |
2007-01-25 |
Kalypsys, Inc. |
Inhibitors of mitotic kinesin
|
JP2007056213A
(ja)
|
2005-08-26 |
2007-03-08 |
Fujifilm Corp |
焼結含油軸受油用組成物、並びにそれを用いた軸受け装置及び摺動部材
|
PL1940821T3
(pl)
|
2005-10-19 |
2013-08-30 |
Gruenenthal Gmbh |
Nowe ligandy receptora waniloidowego i ich zastosowanie do wytwarzania leków
|
FR2892859B1
(fr)
|
2005-10-27 |
2008-06-06 |
Commissariat Energie Atomique |
Procede de greffage de molecules d'interet sur des surfaces inorganiques, surfaces obtenues et applications
|
CA2630920A1
(en)
|
2005-11-22 |
2007-05-31 |
University Of South Florida |
Inhibition of cell proliferation
|
WO2007064869A2
(en)
|
2005-12-01 |
2007-06-07 |
Yale University |
Catalysts for aryl sulfide synthesis and method of producing aryl sulfides
|
JP2008007634A
(ja)
|
2006-06-29 |
2008-01-17 |
Fujifilm Corp |
潤滑剤組成物
|
WO2008024423A2
(en)
|
2006-08-23 |
2008-02-28 |
Xtl Biopharmaceuticals Ltd. |
4-thio substituted quinoline and naphthyridine compounds
|
WO2008028553A1
(en)
|
2006-09-02 |
2008-03-13 |
Merck Patent Gmbh |
Particle beam process for the alignment of reactive mesogens
|
WO2008118626A2
(en)
|
2007-03-08 |
2008-10-02 |
Burnham Institute For Medical Research |
Inhibitors of jnk and methods for identifying inhibitors of jnk
|
US7956020B2
(en)
|
2007-03-29 |
2011-06-07 |
Fujifilm Corporation |
Lubricant composition, mechanical element, and method for producing triazine derivatives
|
WO2008125811A1
(en)
|
2007-04-11 |
2008-10-23 |
Astrazeneca Ab |
N-[HETEROARYLCARBONYL]-S-THIENYL-L-ALANINE DERIVATIVES AS α5β1 ANTAGONISTS
|
TWI519508B
(zh)
|
2007-06-12 |
2016-02-01 |
Achaogen Inc |
抗菌劑
|
US8063165B2
(en)
|
2007-06-18 |
2011-11-22 |
Bridgestone Corporation |
Functional polymers prepared with sulfur-containing initiators
|
JP2009013314A
(ja)
|
2007-07-06 |
2009-01-22 |
Toyo Ink Mfg Co Ltd |
光硬化型インキ
|
CZ2010180A3
(cs)
|
2007-08-21 |
2010-10-13 |
Senomyx, Inc |
Identifikace lidských T2R receptoru, které reagují na horké slouceniny, které vyvolavají horkou chut v kompozicích, a jejich použití v testech pro identifikaci sloucenin, které inhibují (blokují) horkou chut v kompozicích a jejich použití
|
US8143276B2
(en)
|
2007-08-22 |
2012-03-27 |
Xtl Biopharmaceuticals Ltd. |
4-thio substituted quinoline and naphthyridine compounds
|
WO2009030318A1
(de)
|
2007-08-29 |
2009-03-12 |
Merck Patent Gmbh |
Flüssigkristallanzeige
|
EP2183255A4
(en)
|
2007-08-29 |
2011-06-15 |
Methylgene Inc |
METHOD AND INTERMEDIATE PRODUCTS FOR THE PREPARATION OF CONDENSED HETEROCYCLIC KINASE INHIBITORS
|
ES2537352T3
(es)
|
2007-09-12 |
2015-06-05 |
Genentech, Inc. |
Combinaciones de compuestos inhibidores de fosfoinositida 3-cinasa y agentes quimioterapéuticos, y metodos para su uso
|
US8501955B2
(en)
|
2007-10-08 |
2013-08-06 |
Advinus Therapeutics Private Limited |
Acetamide derivatives as glucokinase activators, their process and medicinal application
|
US9340506B2
(en)
|
2007-10-08 |
2016-05-17 |
Advinus Therapeutics Limited |
Acetamide derivatives as glucokinase activators, their process and medicinal applications
|
EP2214675B1
(en)
|
2007-10-25 |
2013-11-20 |
Genentech, Inc. |
Process for making thienopyrimidine compounds
|
RU2501787C2
(ru)
|
2007-11-02 |
2013-12-20 |
Метилджен Инк. |
Ингибиторы гистондеацетилазы
|
WO2009078813A1
(en)
|
2007-12-19 |
2009-06-25 |
Nanyang Technological University |
Method of forming oseltamivir and derivatives thereof
|
EP2098226A1
(de)
|
2008-03-06 |
2009-09-09 |
Forschungsverbund Berlin e.V. |
AKAP-PKA-Interaktionshemmer zur Anwendung in der Behandlung von Herzkrankheiten
|
US8822513B2
(en)
|
2010-03-01 |
2014-09-02 |
Gtx, Inc. |
Compounds for treatment of cancer
|
US8168784B2
(en)
|
2008-06-20 |
2012-05-01 |
Abbott Laboratories |
Processes to make apoptosis promoters
|
US9174969B2
(en)
|
2008-07-21 |
2015-11-03 |
University Of South Florida |
Indoline scaffold SHP-2 inhibitors and cancer treatment method
|
JP5847580B2
(ja)
|
2008-07-28 |
2016-01-27 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung |
液晶ディスプレイ
|
WO2010048149A2
(en)
|
2008-10-20 |
2010-04-29 |
Kalypsys, Inc. |
Heterocyclic modulators of gpr119 for treatment of disease
|
KR101648601B1
(ko)
|
2008-12-22 |
2016-08-16 |
메르크 파텐트 게엠베하 |
액정 디스플레이
|
WO2010075273A1
(en)
|
2008-12-23 |
2010-07-01 |
Schering Corporation |
Bicyclic heterocycle derivatives and methods of use thereof
|
DE102010006691A1
(de)
|
2009-02-06 |
2010-10-28 |
Merck Patent Gmbh |
Flüssigkristallines Medium und Flüssigkristallanzeige
|
WO2010094029A2
(en)
|
2009-02-16 |
2010-08-19 |
University Of South Florida |
Asymmetric cyclopropanation with succinimidyl diazoacetate
|
WO2010096777A1
(en)
|
2009-02-23 |
2010-08-26 |
Presidio Pharmaceuticals, Inc. |
Inhibitors of hcv ns5a
|
JP2010217692A
(ja)
|
2009-03-18 |
2010-09-30 |
Konica Minolta Holdings Inc |
表示素子
|
DK2414369T3
(en)
|
2009-04-02 |
2015-09-21 |
Fundacion Ct Nac Investigaciones Oncologicas Carlos Iii |
Imidazo [2,1-b] [1,3,4] thiadiazole derivatives
|
WO2010115098A2
(en)
|
2009-04-03 |
2010-10-07 |
The Scripps Research Institute |
Palladium-catalyzed ortho-fluorination
|
DE102010012900A1
(de)
|
2009-04-23 |
2010-11-25 |
Merck Patent Gmbh |
Flüssigkristallanzeige
|
KR101705158B1
(ko)
|
2009-05-05 |
2017-02-09 |
다나-파버 캔서 인스티튜트 인크. |
Egfr 억제제 및 질환 치료방법
|
WO2011005355A1
(en)
|
2009-05-07 |
2011-01-13 |
Achaogen, Inc. |
Combinations comprising a lpxc inhibitor and an antibiotic for use in the treatment of infections caused by gram-negative bacteria
|
WO2010147969A2
(en)
|
2009-06-16 |
2010-12-23 |
Schering Corporation |
Gamma secretase modulators
|
US20120232108A1
(en)
|
2009-06-16 |
2012-09-13 |
Xianhai Huang |
Gamma secretase modulators
|
WO2010147975A1
(en)
|
2009-06-16 |
2010-12-23 |
Schering Corporation |
Gamma secretase modulators
|
WO2010151711A1
(en)
|
2009-06-25 |
2010-12-29 |
Alkermes, Inc. |
Prodrugs of nh-acidic compounds
|
WO2010148422A1
(en)
|
2009-06-25 |
2010-12-29 |
Walter And Eliza Hall Institute Of Medical Research |
Compounds and methods for treating parasitic infestations
|
US20120149663A1
(en)
|
2009-08-18 |
2012-06-14 |
Georgetown University |
Boronic acid compositions and methods related to cancer
|
EP2473498A1
(en)
|
2009-09-04 |
2012-07-11 |
Bayer Pharma Aktiengesellschaft |
Substituted aminoquinoxalines as tyrosine threonine kinase inhibitors
|
EP2292720A1
(en)
|
2009-09-08 |
2011-03-09 |
Merck Patent GmbH |
Liquid-crystal display
|
WO2011056929A1
(en)
|
2009-11-04 |
2011-05-12 |
Massachusetts Institute Of Technology |
Continuous flow synthesis of amino alcohols using microreactors
|
KR20110088098A
(ko)
|
2010-01-28 |
2011-08-03 |
다우어드밴스드디스플레이머티리얼 유한회사 |
신규한 유기 발광 화합물 및 이를 채용하고 있는 유기 전계 발광 소자
|
CN102947302A
(zh)
|
2010-02-18 |
2013-02-27 |
西班牙国家癌症研究中心 |
三唑并[4,5-b]吡啶衍生物
|
WO2011109059A1
(en)
|
2010-03-01 |
2011-09-09 |
Gtx, Inc. |
Compounds for treatment of cancer
|
KR20110101444A
(ko)
|
2010-03-08 |
2011-09-16 |
다우어드밴스드디스플레이머티리얼 유한회사 |
신규한 유기 발광 화합물 및 이를 포함하는 유기 발광 소자
|
KR20110104765A
(ko)
|
2010-03-17 |
2011-09-23 |
다우어드밴스드디스플레이머티리얼 유한회사 |
신규한 유기 발광 화합물 및 이를 채용하고 있는 유기 전계 발광 소자
|
US9725479B2
(en)
|
2010-04-22 |
2017-08-08 |
Ionis Pharmaceuticals, Inc. |
5′-end derivatives
|
WO2011140425A1
(en)
|
2010-05-06 |
2011-11-10 |
Vertex Pharmaceuticals Incorporated |
Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels
|
MX351368B
(es)
|
2010-05-26 |
2017-10-12 |
Sunovion Pharmaceuticals Inc |
Compuestos heteroarilo y metodos para utilizarlos.
|
CN103096875B
(zh)
|
2010-06-03 |
2016-08-17 |
阿尔尼拉姆医药品有限公司 |
用于递送活性剂的生物可降解脂质
|
WO2012016133A2
(en)
|
2010-07-29 |
2012-02-02 |
President And Fellows Of Harvard College |
Ros1 kinase inhibitors for the treatment of glioblastoma and other p53-deficient cancers
|
WO2012016217A1
(en)
|
2010-07-29 |
2012-02-02 |
Rigel Pharmaceuticals, Inc. |
Ampk-activating heterocyclic compounds and methods for using the same
|
US20130202652A1
(en)
|
2010-07-30 |
2013-08-08 |
Alnylam Pharmaceuticals, Inc. |
Methods and compositions for delivery of active agents
|
WO2012020215A1
(en)
|
2010-08-09 |
2012-02-16 |
Centro Nacional De Investigaciones Oncológicas (Cnio) |
Amino- imidazolothiadiazoles for use as protein or lipid kinase inhibitors
|
WO2012020357A1
(en)
|
2010-08-09 |
2012-02-16 |
Advinus Therapeutics Ltd. |
Acetamide compounds, their process and pharmaceutical application
|
CA2806634A1
(en)
|
2010-08-20 |
2012-02-23 |
Gruenenthal Gmbh |
Substituted cyclic carboxamide and urea derivatives as ligands of the vanilloid receptor
|
US9463256B2
(en)
|
2010-10-14 |
2016-10-11 |
Koninklijke Philips N.V. |
Pretargeting kit, method and agents used therein
|
WO2012052540A1
(en)
|
2010-10-21 |
2012-04-26 |
Universitaet Des Saarlandes |
Selective cyp11b1 inhibitors for the treatment of cortisol dependent diseases
|
US20120108819A1
(en)
|
2010-10-28 |
2012-05-03 |
Basf Se |
N-Heterocyclic Carbene Complexes, Their Preparation And Use
|
CN103180332A
(zh)
|
2010-10-28 |
2013-06-26 |
巴斯夫欧洲公司 |
N-杂环卡宾配合物、其制备及应用
|
KR20120045905A
(ko)
|
2010-11-01 |
2012-05-09 |
한국화학연구원 |
헤테로고리 축합된 피리도 화합물 및 이의 제조방법
|
US9090633B2
(en)
|
2010-11-18 |
2015-07-28 |
Kasina Laila Innova Pharmaceuticals Private Limited |
Substituted 4-(arylamino) selenophenopyrimidine compounds and methods of use thereof
|
JP2014503528A
(ja)
|
2010-12-14 |
2014-02-13 |
エレクトロプホレトイクス リミテッド |
カゼインキナーゼ1δ(CK1δ)阻害剤及びタウオパチーなどの神経変性疾患の治療におけるその使用
|
RU2013133813A
(ru)
|
2010-12-21 |
2015-01-27 |
Конинклейке Филипс Электроникс Н.В. |
Средства для выведения биомолекул из кровотока
|
US8987271B2
(en)
|
2010-12-22 |
2015-03-24 |
Eutropics Pharmaceuticals, Inc. |
2,2′-biphenazine compounds and methods useful for treating disease
|
JP5618815B2
(ja)
|
2010-12-24 |
2014-11-05 |
富士フイルム株式会社 |
感活性光線性又は感放射線性樹脂組成物、並びに、この組成物を用いた感活性光線性又は感放射線性膜及びパターン形成方法
|
US8883793B2
(en)
|
2010-12-29 |
2014-11-11 |
Development Center For Biotechnology |
Tubulin inhibitors and methods of using the same
|
US9295754B2
(en)
|
2011-02-24 |
2016-03-29 |
Emory University |
Noggin inhibitory compositions for ossification and methods related thereto
|
EP2681196B1
(en)
|
2011-03-04 |
2015-09-09 |
Life Technologies Corporation |
Compounds and methods for conjugation of biomolecules
|
DE102012003796A1
(de)
|
2011-03-18 |
2012-09-20 |
Merck Patent Gmbh |
Flüssigkristallines Medium
|
US9464065B2
(en)
|
2011-03-24 |
2016-10-11 |
The Scripps Research Institute |
Compounds and methods for inducing chondrogenesis
|
JP2014516366A
(ja)
|
2011-03-29 |
2014-07-10 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング |
液晶媒体
|
EP2693883B1
(en)
|
2011-04-07 |
2018-12-26 |
Cornell University |
Silyl monomers capable of multimerizing in an aqueous solution, and methods of using same
|
EP2522369A1
(en)
|
2011-05-09 |
2012-11-14 |
Koninklijke Philips Electronics N.V. |
Pretargeting kit, method and agents used therein
|
CN103635230B
(zh)
|
2011-05-12 |
2017-10-31 |
普罗蒂斯特斯治疗公司 |
蛋白内稳态调节剂
|
AU2012257416B8
(en)
|
2011-05-16 |
2017-10-19 |
Tagworks Pharmaceuticals B.V. |
Bio-orthogonal drug activation
|
EP2524918A1
(en)
|
2011-05-19 |
2012-11-21 |
Centro Nacional de Investigaciones Oncológicas (CNIO) |
Imidazopyrazines derivates as kinase inhibitors
|
JP5782836B2
(ja)
|
2011-05-27 |
2015-09-24 |
コニカミノルタ株式会社 |
有機エレクトロルミネッセンス素子材料、有機エレクトロルミネッセンス素子、表示装置、照明装置、並びに化合物
|
US9073801B2
(en)
|
2011-06-03 |
2015-07-07 |
Massachusetts Institute Of Technology |
Z-selective ring-closing metathesis reactions
|
JP6301830B2
(ja)
|
2011-06-28 |
2018-03-28 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung |
有機半導体としてのインダセノ誘導体
|
EP2729550B1
(en)
|
2011-07-07 |
2018-02-21 |
Merck Patent GmbH |
Liquid-crystalline medium
|
JP2014532084A
(ja)
|
2011-07-08 |
2014-12-04 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung |
共役ポリマー
|
TWI700268B
(zh)
|
2011-09-09 |
2020-08-01 |
美商藍瑟斯醫學影像公司 |
用於合成及使用造影劑之組合物、方法及系統
|
MX352672B
(es)
|
2011-09-27 |
2017-12-04 |
Amgen Inc |
Compuestos heterocíclicos como inhibidores de mdm2 para el tratamiento del cáncer.
|
EP2615083A1
(en)
|
2012-01-10 |
2013-07-17 |
Studiengesellschaft Kohle mbH |
Process for the asymmetric oxidation of organic compounds with peroxides in the presence of a chiral acid catalyst
|
JP5814141B2
(ja)
|
2012-01-23 |
2015-11-17 |
ユー・ディー・シー アイルランド リミテッド |
合成法、その合成法を用いて合成された化合物および有機電界発光素子
|
WO2013124040A1
(en)
|
2012-02-22 |
2013-08-29 |
Merck Patent Gmbh |
Liquid crystalline medium
|
WO2013151739A1
(en)
|
2012-04-03 |
2013-10-10 |
3M Innovative Properties Company |
Crosslinkable composition comprising photobase generators
|
CN104428294B
(zh)
|
2012-04-20 |
2017-07-14 |
拜尔农科股份公司 |
N‑环烷基‑n‑[(杂环基苯基)亚甲基]‑(硫代)羧酰胺衍生物
|
FR2992317B1
(fr)
|
2012-06-22 |
2016-05-13 |
Diverchim |
Procede de preparation de peptides chiraux
|
US8575283B1
(en)
|
2012-06-28 |
2013-11-05 |
Formosa Plastics Corporation, U.S.A. |
Heterocyclic organic compounds as electron donors for polyolefin catalysts
|
WO2014031872A2
(en)
|
2012-08-23 |
2014-02-27 |
The Broad Institute, Inc. |
Small molecule inhibitors for treating parasitic infections
|
AU2013312587B2
(en)
|
2012-09-04 |
2017-03-16 |
Jiangsu Hengrui Medicine Co., Ltd. |
Imidazoline derivatives, preparation methods thereof, and their applications in medicine
|
US9593115B2
(en)
|
2012-09-21 |
2017-03-14 |
Advinus Therapeutics Ltd. |
Substituted fused tricyclic compounds, compositions, and medicinal applications thereof
|
KR101677866B1
(ko)
|
2012-10-29 |
2016-11-18 |
코니카 미놀타 가부시키가이샤 |
위상차 필름, 원편광판 및 화상 표시 장치
|
CA2890948A1
(en)
|
2012-11-16 |
2014-05-22 |
Basf Se |
Lubricant compositions comprising epoxide compounds to improve fluoropolymer seal compatibility
|
FI2922574T3
(fi)
|
2012-11-22 |
2023-08-11 |
Tagworks Pharmaceuticals B V |
Kemiallisesti pilkkoutuva ryhmä
|
WO2014081299A1
(en)
|
2012-11-22 |
2014-05-30 |
Tagworks Pharmaceuticals B.V. |
Activatable liposomes
|
WO2014081300A1
(en)
|
2012-11-22 |
2014-05-30 |
Tagworks Pharmaceuticals B.V. |
Channel protein activatable liposomes
|
WO2014081301A1
(en)
|
2012-11-22 |
2014-05-30 |
Tagworks Pharmaceuticals B.V. |
Bio-orthogonal drug activation
|
WO2014090362A1
(en)
|
2012-12-12 |
2014-06-19 |
Merck Patent Gmbh |
Liquid-crystalline medium
|
JP6335428B2
(ja)
|
2012-12-21 |
2018-05-30 |
出光興産株式会社 |
有機エレクトロルミネッセンス素子および電子機器
|
JP2016506414A
(ja)
|
2013-01-03 |
2016-03-03 |
メルク パテント ゲーエムベーハー |
電子素子のための材料
|
JP6322587B2
(ja)
|
2013-02-08 |
2018-05-09 |
株式会社Joled |
有機エレクトロルミネッセンス素子
|
EP2956441A4
(en)
|
2013-02-18 |
2016-11-02 |
Scripps Research Inst |
MODULATORS OF VASOPRESSIN RECEPTORS WITH THERAPEUTIC POTENTIAL
|
WO2014134141A1
(en)
|
2013-02-26 |
2014-09-04 |
President And Fellows Of Harvard College |
Synthesis of acyclic and cyclic amines using iron-catalyzed nitrene group transfer
|
US9580400B2
(en)
|
2013-02-26 |
2017-02-28 |
Northeastern University |
Cannabinergic nitrate esters and related analogs
|
WO2014141129A2
(en)
|
2013-03-14 |
2014-09-18 |
Grueneberg Dorre A |
Novel methods, compounds, and compositions for inhibition of ros
|
US9290528B1
(en)
|
2013-03-15 |
2016-03-22 |
University Of Kentucky Research Foundation |
Light-activated compounds
|
JP5902641B2
(ja)
|
2013-03-27 |
2016-04-13 |
富士フイルム株式会社 |
光干渉顔料およびその製造方法
|
WO2014165827A1
(en)
|
2013-04-05 |
2014-10-09 |
Salk Institute For Biological Studies |
Ppar agonists
|
KR102177883B1
(ko)
|
2013-04-08 |
2020-11-12 |
메르크 파텐트 게엠베하 |
유기 전계발광 디바이스
|
EP2984692B1
(de)
|
2013-04-08 |
2018-01-31 |
Merck Patent GmbH |
Organische elektrolumineszenzvorrichtung mit thermisch aktiviertem verzögertem fluoreszenzmaterial
|
WO2014176488A1
(en)
|
2013-04-26 |
2014-10-30 |
Indiana University Research & Technology Corporation |
Hydroxyindole carboxylic acid based inhibitors for oncogenic src homology-2 domain containing protein tyrosine phosphatase-2 (shp2)
|
JP2014232188A
(ja)
|
2013-05-29 |
2014-12-11 |
コニカミノルタ株式会社 |
セルロースアシレートフィルム、円偏光板及び画像表示装置
|
WO2015003094A2
(en)
|
2013-07-03 |
2015-01-08 |
Indiana University Research & Technology Corporation |
Shp2 inhibitors and methods of treating autoimmune and/or glomerulonephritis-associated diseases using shp2 inhibitors
|
WO2015003146A1
(en)
|
2013-07-03 |
2015-01-08 |
Georgetown University |
Boronic acid derivatives of resveratrol for activating deacetylase enzymes
|
WO2015003137A1
(en)
|
2013-07-03 |
2015-01-08 |
University Of Connecticut |
Polymerization of diene monomers
|
GB201312991D0
(en)
|
2013-07-19 |
2013-09-04 |
Isis Innovation |
Process
|
KR102252761B1
(ko)
|
2013-08-02 |
2021-05-18 |
메르크 파텐트 게엠베하 |
액정 매질
|
US20160257657A1
(en)
|
2013-09-20 |
2016-09-08 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Small molecule inhibitors of the nuclear translocation of androgen receptor for the treatment of castration-resistant prostate cancer
|
WO2015042375A1
(en)
|
2013-09-20 |
2015-03-26 |
Idenix Pharmaceuticals, Inc. |
Hepatitis c virus inhibitors
|
US20150087673A1
(en)
|
2013-09-26 |
2015-03-26 |
Rigel Pharmaceuticals, Inc. |
Methods for using and biomarkers for ampk-activating compounds
|
KR101628288B1
(ko)
|
2013-09-30 |
2016-06-08 |
주식회사 엘지화학 |
음성 광학 분산도를 갖는 광학 소자 제조용 조성물 및 이로부터 제조된 광학 이방체
|
EP2857405A1
(en)
|
2013-10-01 |
2015-04-08 |
Studiengesellschaft Kohle mbH |
Process for the trans-selective hydroboration of internal alkynes
|
WO2015061247A2
(en)
|
2013-10-21 |
2015-04-30 |
Merck Patent Gmbh |
Heteroaryl compounds as btk inhibitors and uses thereof
|
JP6522313B2
(ja)
|
2013-10-24 |
2019-05-29 |
出光興産株式会社 |
有機エレクトロルミネッセンス素子および電子機器
|
JP6088995B2
(ja)
|
2013-10-24 |
2017-03-01 |
出光興産株式会社 |
有機エレクトロルミネッセンス素子および電子機器
|
KR101537860B1
(ko)
|
2013-11-22 |
2015-07-20 |
롯데케미칼 주식회사 |
내감마선 성능이 향상된 폴리카보네이트 수지 조성물 및 이를 이용한 성형품
|
JP6215674B2
(ja)
|
2013-11-29 |
2017-10-18 |
出光興産株式会社 |
有機エレクトロルミネッセンス素子および電子機器
|
JP6309834B2
(ja)
|
2013-12-11 |
2018-04-11 |
株式会社Adeka |
着色性組成物
|
JP2015163671A
(ja)
|
2013-12-13 |
2015-09-10 |
株式会社Adeka |
ラジカル重合性組成物
|
KR20150070027A
(ko)
|
2013-12-16 |
2015-06-24 |
메르크 파텐트 게엠베하 |
액정 매질
|
US10020455B2
(en)
|
2014-01-07 |
2018-07-10 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Tetradentate platinum and palladium complex emitters containing phenyl-pyrazole and its analogues
|
CA2935944A1
(en)
|
2014-01-09 |
2015-07-16 |
The J. David Gladstone Institutes, A Testamentary Trust Established Under The Will Of J. David Gladstone |
Substituted benzoxazine and related compounds
|
EP3094629B1
(en)
|
2014-01-17 |
2018-08-22 |
Novartis AG |
1-(triazin-3-yl/pyridazin-3-yl)-piper(-azine)idine derivatives and compositions thereof for inhibiting the activity of shp2
|
JO3517B1
(ar)
|
2014-01-17 |
2020-07-05 |
Novartis Ag |
ان-ازاسبيرو الكان حلقي كبديل مركبات اريل-ان مغايرة وتركيبات لتثبيط نشاط shp2
|
EP3094627B1
(en)
|
2014-01-17 |
2018-08-22 |
Novartis AG |
1-pyridazin-/triazin-3-yl-piper(-azine)/idine/pyrolidine derivatives and and compositions thereof for inhibiting the activity of shp2
|
KR20150091942A
(ko)
|
2014-02-04 |
2015-08-12 |
삼성전자주식회사 |
유기금속 화합물 및 이를 포함한 유기 발광 소자
|
JP6313604B2
(ja)
|
2014-02-05 |
2018-04-18 |
富士フイルム株式会社 |
感活性光線性又は感放射線性樹脂組成物、感活性光線性又は感放射線性膜、感活性光線性又は感放射線性膜を備えたマスクブランクス、パターン形成方法、及び電子デバイスの製造方法
|
EP3110794A1
(en)
|
2014-02-27 |
2017-01-04 |
Merck Patent GmbH |
Heterocyclic compounds as nav channel inhibitors and uses thereof
|
US20170029366A1
(en)
|
2014-03-07 |
2017-02-02 |
The Johns Hopkins University |
Inhibitors of histone lysine specific demethylase (lsd1) and histone deacetylases (hdacs)
|
PT3143011T
(pt)
|
2014-05-13 |
2021-04-26 |
Hoffmann La Roche |
Compostos heterocíclicos deuterados e a sua utilização como agentes de imagiologia
|
SI3142637T1
(sl)
|
2014-05-16 |
2021-01-29 |
Olaplex, Inc. |
Zdravilne formulacije keratina in postopki
|
EP3145925B1
(en)
|
2014-05-19 |
2020-11-04 |
Boehringer Ingelheim Animal Health USA Inc. |
Anthelmintic compounds
|
CA2948888A1
(en)
|
2014-06-05 |
2015-12-10 |
Merck Patent Gmbh |
Novel quinoline derivatives and their use in neurodegenerative diseases
|
US20170174826A1
(en)
|
2014-07-16 |
2017-06-22 |
Agency For Science, Technology And Research |
Donor-acceptor polymers
|
US9818959B2
(en)
|
2014-07-29 |
2017-11-14 |
Arizona Board of Regents on behlaf of Arizona State University |
Metal-assisted delayed fluorescent emitters containing tridentate ligands
|
WO2016022645A1
(en)
|
2014-08-06 |
2016-02-11 |
Merck Sharp & Dohme Corp. |
Heterocyclic cgrp receptor antagonists
|
EP2985334B1
(en)
|
2014-08-15 |
2018-06-20 |
Merck Patent GmbH |
Liquid-crystalline medium
|
WO2016031785A1
(ja)
|
2014-08-26 |
2016-03-03 |
出光興産株式会社 |
有機エレクトロルミネッセンス素子および電子機器
|
US10205190B2
(en)
|
2014-08-28 |
2019-02-12 |
Samsung Electronics Co., Ltd. |
Composite electrolyte including polymeric ionic liquid and inorganic particles and lithium battery including the same
|
WO2016049565A1
(en)
|
2014-09-25 |
2016-03-31 |
Araxes Pharma Llc |
Compositions and methods for inhibition of ras
|
EP3230279A1
(en)
|
2014-12-10 |
2017-10-18 |
Massachusetts Institute of Technology |
Fused 1,3-azole derivatives useful for the treatment of proliferative diseases
|
KR102384224B1
(ko)
|
2014-12-30 |
2022-04-08 |
삼성전자주식회사 |
축합환 화합물 및 이를 포함한 유기 발광 소자
|
WO2016145383A1
(en)
|
2015-03-11 |
2016-09-15 |
Board Of Regents, University Of Texas System |
Mth1 inhibitors for treating disease
|
KR102434696B1
(ko)
|
2015-03-13 |
2022-08-22 |
삼성전자주식회사 |
유기금속 화합물 및 이를 포함한 유기 발광 소자
|
AU2016245864C1
(en)
|
2015-04-10 |
2021-09-09 |
Araxes Pharma Llc |
Substituted quinazoline compounds and methods of use thereof
|
CA2982360A1
(en)
|
2015-04-15 |
2016-10-20 |
Liansheng Li |
Fused-tricyclic inhibitors of kras and methods of use thereof
|
AU2016258087B2
(en)
|
2015-05-07 |
2020-01-02 |
Bristol-Myers Squibb Company |
Tricyclic sulfones as RORϒ modulators
|
US9458308B1
(en)
|
2015-05-12 |
2016-10-04 |
Lotte Chemical Corporation |
Polycarbonate resin composition with increased gamma-radiation resistant property and molded article using the same
|
US9879039B2
(en)
|
2015-06-03 |
2018-01-30 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Tetradentate and octahedral metal complexes containing naphthyridinocarbazole and its analogues
|
JP6878316B2
(ja)
*
|
2015-06-19 |
2021-05-26 |
ノバルティス アーゲー |
Shp2の活性を阻害するための化合物および組成物
|
ES2805232T3
(es)
|
2015-06-19 |
2021-02-11 |
Novartis Ag |
Compuestos y composiciones para inhibir la actividad de SHP2
|
EP3310779B1
(en)
|
2015-06-19 |
2019-05-08 |
Novartis AG |
Compounds and compositions for inhibiting the activity of shp2
|
FR3037952B1
(fr)
|
2015-06-24 |
2019-01-25 |
Compagnie Generale Des Etablissements Michelin |
Procede de synthese d'oximes aromatiques
|
EP3112440B1
(en)
|
2015-07-02 |
2019-07-24 |
Merck Patent GmbH |
Liquid-crystal medium
|
EP3325447A1
(en)
|
2015-07-22 |
2018-05-30 |
Araxes Pharma LLC |
Substituted quinazoline compounds and their use as inhibitors of g12c mutant kras, hras and/or nras proteins
|
GB201514018D0
(en)
|
2015-08-07 |
2015-09-23 |
Arnér Elias S J And United States Of America Asrepresented By The Sec Dep Of Health And Human Servic |
Novel tricyclic compounds and their use in the treatment of cancer
|
GB201514015D0
(en)
|
2015-08-07 |
2015-09-23 |
Arnér Elias S J And Dept Of Health And Human Services |
Novel pyridazinones and their use in the treatment of cancer
|
US10201531B2
(en)
|
2015-08-12 |
2019-02-12 |
Mochida Pharmaceutical Co., Ltd. |
Indazolyl-oxo-isothiazole compounds
|
EP3133078B1
(en)
|
2015-08-18 |
2019-01-30 |
Samsung Electronics Co., Ltd. |
Organometallic compound and organic light-emitting device including the same
|
KR101796227B1
(ko)
|
2015-08-21 |
2017-11-10 |
삼성디스플레이 주식회사 |
유기 발광 소자
|
US10240085B2
(en)
|
2015-08-27 |
2019-03-26 |
Samsung Electronics Co., Ltd. |
Thin film and organic light-emitting device including the same
|
KR102542465B1
(ko)
|
2015-09-22 |
2023-06-12 |
삼성전자주식회사 |
유기금속 화합물 및 이를 포함한 유기 발광 소자
|
WO2017058792A1
(en)
|
2015-09-28 |
2017-04-06 |
Araxes Pharma Llc |
Inhibitors of kras g12c mutant proteins
|
WO2017058768A1
(en)
|
2015-09-28 |
2017-04-06 |
Araxes Pharma Llc |
Inhibitors of kras g12c mutant proteins
|
US10689356B2
(en)
|
2015-09-28 |
2020-06-23 |
Araxes Pharma Llc |
Inhibitors of KRAS G12C mutant proteins
|
EP3356353A1
(en)
|
2015-09-28 |
2018-08-08 |
Araxes Pharma LLC |
Inhibitors of kras g12c mutant proteins
|
US10875842B2
(en)
|
2015-09-28 |
2020-12-29 |
Araxes Pharma Llc |
Inhibitors of KRAS G12C mutant proteins
|
US10975071B2
(en)
|
2015-09-28 |
2021-04-13 |
Araxes Pharma Llc |
Inhibitors of KRAS G12C mutant proteins
|
US10730867B2
(en)
|
2015-09-28 |
2020-08-04 |
Araxes Pharma Llc |
Inhibitors of KRAS G12C mutant proteins
|
SE541053C2
(sv)
|
2015-09-30 |
2019-03-19 |
Epiroc Rock Drills Ab |
System och förfarande för borrplansgenerering, borrigg, datorprogram samt datorprogramprodukt
|
CA3001857A1
(en)
|
2015-10-14 |
2017-04-20 |
Aquinnah Pharmaceuticals, Inc. |
Compounds, compositions and methods of use against stress granules
|
JP2018533939A
(ja)
|
2015-10-19 |
2018-11-22 |
アラクセス ファーマ エルエルシー |
Rasの阻害剤をスクリーニングするための方法
|
EP3162875B1
(en)
|
2015-10-30 |
2018-05-23 |
Merck Patent GmbH |
Polymerisable compounds and the use thereof in liquid-crystal displays
|
ES2895904T3
(es)
|
2015-11-02 |
2022-02-23 |
Genase Therapeutics B V |
Tetrahidroindazoles y usos médicos de los mismos
|
MX2018005967A
(es)
|
2015-11-16 |
2018-08-29 |
Araxes Pharma Llc |
Compuestos de quinazolina 2-sustituida que comprenden un grupo heterociclico sustituido y metodos de uso de los mismos.
|
WO2017100546A1
(en)
|
2015-12-09 |
2017-06-15 |
Araxes Pharma Llc |
Methods for preparation of quinazoline derivatives
|
KR20170069342A
(ko)
|
2015-12-10 |
2017-06-21 |
삼성디스플레이 주식회사 |
유기 발광 소자
|
CN106892924B
(zh)
|
2015-12-17 |
2021-01-08 |
四川科伦博泰生物医药股份有限公司 |
短效苯并二氮*衍生物、其制备方法及其用途
|
KR102579752B1
(ko)
|
2015-12-22 |
2023-09-19 |
삼성디스플레이 주식회사 |
유기 발광 소자
|
KR20170075118A
(ko)
|
2015-12-22 |
2017-07-03 |
삼성디스플레이 주식회사 |
유기 발광 소자
|
US10336772B2
(en)
|
2015-12-28 |
2019-07-02 |
Samsung Electronics Co., Ltd. |
Bicarbazole compound, material for organic light-emitting device including bicarbazole compound, and organic light-emitting device including bicarbazole compound
|
KR102419178B1
(ko)
|
2015-12-29 |
2022-07-11 |
삼성디스플레이 주식회사 |
유기 발광 소자
|
KR102396293B1
(ko)
|
2015-12-29 |
2022-05-11 |
삼성디스플레이 주식회사 |
유기 발광 소자
|
US10072017B2
(en)
|
2015-12-30 |
2018-09-11 |
Flatley Discovery Lab, Llc |
Compounds and methods for the treatment of cystic fibrosis
|
EP3190164B1
(en)
|
2016-01-05 |
2019-07-24 |
Samsung Electronics Co., Ltd |
Composition, thin film including the composition, and organic light-emitting device including the composition or the thin film
|
KR102633852B1
(ko)
|
2016-01-25 |
2024-02-07 |
삼성디스플레이 주식회사 |
카바졸계 화합물 및 이를 포함한 유기 발광 소자
|
JP6987064B2
(ja)
|
2016-02-08 |
2021-12-22 |
ハー・ルンドベック・アクチエゼルスカベット |
1−[2−(2,4−ジメチル−フェニルスルファニル)−フェニル]ピペラジンの合成
|
KR102628850B1
(ko)
|
2016-03-07 |
2024-01-25 |
삼성디스플레이 주식회사 |
축합환 화합물 및 이를 포함한 유기 발광 소자
|
WO2017156265A1
(en)
|
2016-03-09 |
2017-09-14 |
President And Fellows Of Harvard College |
Direct palladium-catalyzed aromatic fluorination
|
MD3429591T2
(ro)
|
2016-03-16 |
2023-08-31 |
Kura Oncology Inc |
Derivați de tieno[2,3-d]pirimidină substituiți în calitate de inhibitori ai menin-MLL și procedee de utilizare
|
US10822312B2
(en)
|
2016-03-30 |
2020-11-03 |
Araxes Pharma Llc |
Substituted quinazoline compounds and methods of use
|
WO2017170263A1
(ja)
|
2016-03-31 |
2017-10-05 |
株式会社Dnpファインケミカル |
感光性着色樹脂組成物、カラーフィルタ及びその製造方法、並びに表示装置
|
KR102606277B1
(ko)
|
2016-04-06 |
2023-11-27 |
삼성디스플레이 주식회사 |
유기 발광 소자
|
KR102642199B1
(ko)
|
2016-04-07 |
2024-03-05 |
삼성디스플레이 주식회사 |
유기 발광 소자
|
JP7039489B2
(ja)
|
2016-05-18 |
2022-03-22 |
ミラティ セラピューティクス, インコーポレイテッド |
Kras g12c阻害剤
|
JP7044375B2
(ja)
|
2016-05-31 |
2022-03-30 |
ボード オブ リージェンツ,ザ ユニバーシティ オブ テキサス システム |
Ptpn11の複素環式阻害剤
|
CN112250670B
(zh)
*
|
2016-06-07 |
2021-06-08 |
北京加科思新药研发有限公司 |
可用作shp2抑制剂的新型杂环衍生物
|
KR102666178B1
(ko)
|
2016-06-07 |
2024-05-14 |
삼성디스플레이 주식회사 |
유기 발광 소자
|
PL3468972T3
(pl)
|
2016-06-14 |
2020-11-16 |
Novartis Ag |
Związki i kompozycje do hamowania aktywności shp2
|
WO2017222958A1
(en)
|
2016-06-20 |
2017-12-28 |
Kura Oncology, Inc. |
Treatment of squamous cell carcinomas with inhibitors of erk
|
US20180002604A1
(en)
|
2016-06-30 |
2018-01-04 |
Merck Patent Gmbh |
Liquid-crystalline medium
|
IL264186B1
(en)
|
2016-07-12 |
2024-04-01 |
Revolution Medicines Inc |
2,5-dimutomers of 3-methylpyrazines and 2,5,6-dimutomers of 3-methylpyrazines as allosteric SHP2 inhibitors
|
US11299673B2
(en)
|
2016-08-12 |
2022-04-12 |
Merck Patent Gmbh |
Liquid-crystal medium
|
KR20180019803A
(ko)
|
2016-08-16 |
2018-02-27 |
삼성디스플레이 주식회사 |
유기 발광 소자
|
US11529347B2
(en)
|
2016-09-22 |
2022-12-20 |
Relay Therapeutics, Inc. |
SHP2 phosphatase inhibitors and methods of use thereof
|
JP6589795B2
(ja)
|
2016-09-27 |
2019-10-16 |
信越化学工業株式会社 |
スルホニウム塩、レジスト組成物及びパターン形成方法
|
CN109790468B
(zh)
|
2016-09-28 |
2023-06-13 |
默克专利股份有限公司 |
可聚合的液晶材料及经聚合的液晶膜
|
WO2018064510A1
(en)
|
2016-09-29 |
2018-04-05 |
Araxes Pharma Llc |
Inhibitors of kras g12c mutant proteins
|
WO2018062276A1
(ja)
|
2016-09-29 |
2018-04-05 |
住友化学株式会社 |
発光素子
|
CN110312711A
(zh)
|
2016-10-07 |
2019-10-08 |
亚瑞克西斯制药公司 |
作为ras抑制剂的杂环化合物及其使用方法
|
EP3526218B1
(en)
|
2016-10-13 |
2021-04-21 |
Bristol-Myers Squibb Company |
Heterocyclic sulfones as ror gamma modulators
|
WO2018081091A1
(en)
|
2016-10-24 |
2018-05-03 |
Relay Therapeutics, Inc. |
Pyrazolo[3,4-b]pyrazine derivatives as shp2 phosphatase inhibitors
|
WO2018089402A1
(en)
|
2016-11-09 |
2018-05-17 |
Bristol-Myers Squibb Company |
Tricyclic sulfones as ror gamma modulators
|
UA124474C2
(uk)
|
2016-12-22 |
2021-09-22 |
Емджен Інк. |
БЕНЗІЗОТІАЗОЛЬНІ, ІЗОТІАЗОЛО[3,4-b]ПІРИДИНОВІ, ХІНАЗОЛІНОВІ, ФТАЛАЗИНОВІ, ПІРИДО[2,3-d]ПІРИДАЗИНОВІ Й ПІРИДО[2,3-d]ПІРИМІДИНОВІ ПОХІДНІ ЯК ІНГІБІТОРИ G12C KRAS ДЛЯ ЛІКУВАННЯ РАКУ ЛЕГЕНІ, РАКУ ПІДШЛУНКОВОЇ ЗАЛОЗИ АБО КОЛОРЕКТАЛЬНОГО РАКУ
|
US20180177784A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
KR102571130B1
(ko)
|
2017-01-10 |
2023-08-28 |
노파르티스 아게 |
Alk 저해제 및 shp2 저해제를 포함하는 약제학적 조합
|
SG11201906412SA
(en)
|
2017-01-23 |
2019-08-27 |
Revolution Medicines Inc |
Pyridine compounds as allosteric shp2 inhibitors
|
JP7240319B2
(ja)
|
2017-01-23 |
2023-03-15 |
レヴォリューション・メディスンズ,インコーポレイテッド |
アロステリックshp2阻害剤としての二環式化合物
|
JP2020506244A
(ja)
|
2017-02-07 |
2020-02-27 |
オブリーク セラピューティクス アーベー |
ヘテロシクリルスルホニル置換ピリジンおよび癌の治療におけるそれらの使用
|
KR20190115013A
(ko)
|
2017-02-07 |
2019-10-10 |
오블리크 세러퓨틱스 에이비 |
헤테로아릴설포닐-치환된 피리딘 및 암의 치료에서 이의 용도
|
WO2018161033A1
(en)
|
2017-03-02 |
2018-09-07 |
Wright, Adrian |
Small molecule ire1-alpha inhibitors
|
SG11201908820VA
(en)
|
2017-03-23 |
2019-10-30 |
Jacobio Pharmaceuticals Co Ltd |
Novel heterocyclic derivatives useful as shp2 inhibitors
|
KR102395784B1
(ko)
|
2017-03-27 |
2022-05-10 |
삼성전자주식회사 |
유기금속 화합물 및 이를 포함한 유기 발광 소자
|
KR102461719B1
(ko)
|
2017-05-23 |
2022-11-01 |
삼성전자주식회사 |
유기금속 화합물, 이를 포함한 유기 발광 소자 및 이를 포함한 진단용 조성물
|
EP3630770A1
(en)
|
2017-05-26 |
2020-04-08 |
Relay Therapeutics, Inc. |
Pyrazolo[3,4-b]pyrazine derivatives as shp2 phosphatase inhibitors
|
WO2018230595A1
(ja)
|
2017-06-14 |
2018-12-20 |
富士フイルム株式会社 |
組成物、膜、レンズ、固体撮像素子、化合物
|
KR20180137311A
(ko)
|
2017-06-16 |
2018-12-27 |
삼성전자주식회사 |
유기금속 화합물, 이를 포함한 유기 발광 소자 및 이를 포함한 진단용 조성물
|
EP3645528A1
(en)
|
2017-06-26 |
2020-05-06 |
Esteve Pharmaceuticals, S.A. |
Compounds having multimodal activity against pain
|
WO2019018119A1
(en)
|
2017-07-18 |
2019-01-24 |
Pairnomix, Llc |
METHODS FOR TREATING EPILEPSY AND DISORDERS ASSOCIATED WITH KCNTI
|
KR20190014187A
(ko)
|
2017-07-27 |
2019-02-12 |
삼성디스플레이 주식회사 |
유기금속 화합물 및 이를 포함하는 유기 발광 소자
|
GB201712110D0
(en)
|
2017-07-27 |
2017-09-13 |
Thomas Helledays Stiftelse För Medicinsk Forskning |
New compounds and uses
|
JP7346015B2
(ja)
|
2017-09-06 |
2023-09-19 |
住友化学株式会社 |
発光素子
|
KR20200051684A
(ko)
|
2017-09-07 |
2020-05-13 |
레볼루션 메디슨즈, 인크. |
암 치료를 위한 shp2 억제제 조성물 및 방법
|
CN111201223B
(zh)
|
2017-09-11 |
2024-07-09 |
克鲁松制药公司 |
SHP2的八氢环戊二烯并[c]吡咯别构抑制剂
|
KR102526756B1
(ko)
|
2017-09-29 |
2023-04-27 |
삼성전자주식회사 |
유기금속 화합물, 이를 포함한 유기 발광 소자 및 이를 포함한 진단용 조성물
|
EP3687997A1
(en)
|
2017-09-29 |
2020-08-05 |
Relay Therapeutics, Inc. |
Pyrazolo[3,4-b]pyrazine derivatives as shp2 phosphatase inhibitors
|
CN111148819B
(zh)
|
2017-09-29 |
2023-06-16 |
默克专利股份有限公司 |
可聚合化合物及其在液晶显示器中的用途
|
TW201930292A
(zh)
|
2017-10-12 |
2019-08-01 |
美商銳新醫藥公司 |
作為變構shp2抑制劑的吡啶、吡嗪和三嗪化合物
|
KR102518722B1
(ko)
|
2017-11-21 |
2023-04-07 |
삼성디스플레이 주식회사 |
유기금속 화합물 및 이를 포함한 유기 발광 소자
|
MX2020006273A
(es)
|
2017-12-15 |
2020-09-14 |
Revolution Medicines Inc |
Compuestos policiclicos como inhibidores alostericos de shp2.
|
CA3085147A1
(en)
|
2017-12-22 |
2019-06-27 |
Petra Pharma Corporation |
Chromenopyridine derivatives as phosphatidylinositol phosphate kinase inhibitors
|
US11572370B2
(en)
|
2018-01-08 |
2023-02-07 |
Biohaven Therapeutics Ltd. |
CD16A binding agents and uses thereof
|
KR102595918B1
(ko)
|
2018-01-18 |
2023-11-14 |
삼성디스플레이 주식회사 |
유기금속 화합물, 이를 포함한 유기 발광 소자 및 상기 유기 발광 소자를 포함한 유기 발광 장치
|
CN110066276B
(zh)
|
2018-01-24 |
2020-09-18 |
上海璎黎药业有限公司 |
芳香杂环化合物、其中间体、制备方法、药物组合物和应用
|
CN110066277B
(zh)
|
2018-01-24 |
2021-07-23 |
上海璎黎药业有限公司 |
芳香杂环取代烯烃化合物、其制备方法、药物组合物和应用
|
EP3753941B1
(en)
|
2018-02-13 |
2024-05-01 |
Shanghai Blueray Biopharma Co., Ltd. |
Pyrimidine-fused cyclic compound, preparation method therefor and application thereof
|
KR20190098676A
(ko)
|
2018-02-13 |
2019-08-22 |
삼성디스플레이 주식회사 |
유기 발광 소자 및 이를 포함한 표시 장치
|
WO2019165073A1
(en)
|
2018-02-21 |
2019-08-29 |
Relay Therapeutics, Inc. |
Shp2 phosphatase inhibitors and methods of use thereof
|
CN111902415A
(zh)
|
2018-03-02 |
2020-11-06 |
大冢制药株式会社 |
药学化合物
|
US20190280215A1
(en)
|
2018-03-08 |
2019-09-12 |
Samsung Display Co., Ltd. |
Organic light-emitting device
|
US11004918B2
(en)
|
2018-03-09 |
2021-05-11 |
Samsung Display Co., Ltd. |
Electronic apparatus
|
JP7265275B2
(ja)
|
2018-03-21 |
2023-04-26 |
スージョウ プーヘー バイオファーマ カンパニー リミテッド |
Shp2阻害剤およびその使用
|
CA3094690A1
(en)
|
2018-03-21 |
2019-09-26 |
Relay Therapeutics, Inc. |
Shp2 phosphatase inhibitors and methods of use thereof
|
EP3768680A1
(en)
|
2018-03-21 |
2021-01-27 |
Relay Therapeutics, Inc. |
Pyrazolo[3,4-b]pyrazine shp2 phosphatase inhibitors and methods of use thereof
|
CN108794485B
(zh)
|
2018-04-28 |
2020-04-24 |
北京施安泰医药技术开发有限公司 |
一类toll样受体调节剂、其药物组合物、制备方法与用途
|
EP3787627A4
(en)
|
2018-05-02 |
2021-12-01 |
Navire Pharma, Inc. |
SUBSTITUTED HETEROCYCLIC INHIBITORS FOR PTPN11
|
CN110492006B
(zh)
|
2018-05-14 |
2020-06-12 |
江苏三月光电科技有限公司 |
一种基于含硼有机化合物的电致发光器件
|
CN108840886A
(zh)
|
2018-06-22 |
2018-11-20 |
南京工业大学 |
一种铂配合物蓝光材料以及有机发光器件
|
MX2021000795A
(es)
|
2018-07-24 |
2021-04-12 |
Taiho Pharmaceutical Co Ltd |
Compuestos heterociclicos para inhibir la actividad de shp2.
|
CN108863982B
(zh)
|
2018-08-04 |
2022-02-01 |
南昌航空大学 |
一种吩噻嗪/吩恶嗪类化合物的有机电合成方法
|
WO2020033286A1
(en)
|
2018-08-06 |
2020-02-13 |
Purdue Research Foundation |
Novel sesquiterpenoid analogs
|
CA3109181A1
(en)
|
2018-08-10 |
2020-02-13 |
Navire Pharma, Inc. |
6-(4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl)-3-(2,3-dichlorophenyl)-2-methylpyrimidin-4(3h)-one derivatives and related compounds as ptpn11 (shp2) inhibitors for treating cancer
|
EP3853234A1
(en)
|
2018-09-18 |
2021-07-28 |
Nikang Therapeutics, Inc. |
Fused tricyclic ring derivatives as src homology-2 phosphatase inhibitors
|
CN112867718A
(zh)
|
2018-09-29 |
2021-05-28 |
诺华股份有限公司 |
用于抑制shp2活性的化合物和组合物的制造
|
IL305106A
(en)
|
2018-09-29 |
2023-10-01 |
Novartis Ag |
A process for producing a compound to inhibit the activity of SHP2
|
JP2022508651A
(ja)
|
2018-10-08 |
2022-01-19 |
レヴォリューション・メディスンズ,インコーポレイテッド |
癌を処置するためのshp2阻害剤組成物および方法
|